Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas will participate on a panel entitled "Invest Globally: A Framework for Building Great Companies" at the CED's Globalization 2008 Conference
News | 02. 14. 2008
